XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 14, 2022
Jan. 21, 2021
Dec. 02, 2020
Jan. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]                
Stock-based compensation expense         $ 220,000 $ 99,000 $ 306,000 $ 208,000
Options expired         0 13,845    
Warrants exercise price $ 1.00              
Purchase of warrants 250,000              
Proceeds from Warrant Exercises             1,406,000
Warrants, modification expense         $ 8,000 $ 2,000 10,000 $ 2,000
Warrants expire date Jun. 14, 2029              
Increase in additional paid in capital warrants $ 135,000,000              
New Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Warrants exercise price   $ 1.04            
Purchase of warrants   1,205,967            
Proceeds from Warrant Exercises   $ 1,400,000            
Warrants, modification expense           1,627,000    
Two Investors [Member] | Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Stock issued during period warrants       1,657,144        
Warrants exercise price       $ 0.001        
Securities Purchase Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Gross proceeds from private placement     $ 6,000,000.0          
Net proceeds from private placement     $ 5,400,000          
Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Sale of stock, number of shares issued     2,657,144          
Sale of stock, price per share     $ 0.699          
Employee Stock [Member]                
Subsidiary, Sale of Stock [Line Items]                
Non-vested stock options granted, unrecognized estimated compensation cost         390,000   $ 390,000  
Non-vested stock options granted, weighted average period             2 years 6 months  
Private Placement [Member] | Securities Purchase Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Sale of stock, number of shares issued     5,914,285          
Sale of stock, price per share     $ 0.70          
Employees and Consultants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of options, granted             120,000 180,000
Fair value options vesting term             3 years 3 years
Stock-based compensation expense         $ 220,000 $ 99,000 $ 306,000 $ 208,000
Accredited Investors [Member] | Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Warrants exercise price   $ 1.165            
Purchase of warrants   1,205,968